Skip to main content
Clinical Trials/DRKS00011344
DRKS00011344
Completed
Not Applicable

Identifikation of parameters for the development of a Score to predict the non-compliance of patients with recurrent ovarian cancer undergoing a routine therapy with Ovastat(R).A non-interventional observation trial (NIS) - SCORE trial

medac Gesellschaft für klinische Spezialpräparate mbH0 sites194 target enrollmentNovember 21, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C56
Sponsor
medac Gesellschaft für klinische Spezialpräparate mbH
Enrollment
194
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2016
End Date
November 24, 2023
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with recurrent ovarian cancer who have decided to undergo a chemotherapy with treosulfan
  • \- patients aged 18 years or older
  • \- patients who are able to answer questionaires in german language
  • \- willingness to answer questionaires
  • \- before entering the trial informed consent and data privacy statement must be signed by the patient

Exclusion Criteria

  • contemporaneous partizipation in a different clinical trial during the time of treatment or within the last 30 days.
  • \- hypersensitivity to treosulfan
  • \- patients with missing or reduced legal competence
  • \- patients in an instituion due to a legal or governmental order
  • \- pregnant and breast\-feeding women
  • \- no anamnesis form (contains only data collected in routine anamnesis)

Outcomes

Primary Outcomes

Not specified

Similar Trials